Acthar is used to induce a diuresis or a remission of proteinuria in nephrotic syndrome without uremia of the idiopathic type or that due to lupus erythematosus.
*Based solely on prescription data. The number of patients treated and any clinical outcomes of such patients are unknown.
Get additional information on proteinuria in nephrotic syndrome and treating your patients with Acthar.
Programs that help make Acthar available and affordable to patients—and support services to help patients start and stay on therapy.